Access to Safe Contraception Act of 2022

Bill: 117-hr-8421
Sponsor: full_name: Rep. Bice, Stephanie I. [R-OK-5]
Introduced: 2022-07-19
Policy area: Health
Subjects: Family planning and birth control

Federal preemption

Sex and reproductive health

Women's health
Latest action: action_date: 2022-07-21
text: Sponsor introductory remarks on measure. (CR H6937)

Summaries:
action_date: 2022-07-19
action_desc: Introduced in House
text: <p><b>Access to Safe Contraception Act of 2022</b></p> <p>This bill prohibits states from banning any form of contraception that is approved by the Food and Drug Administration. The bill does not preempt state laws that protect the right of any entity to opt out of providing contraception due to the entity's religious or moral beliefs.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 8421 IN THE HOUSE OF REPRESENTATIVES July 19, 2022 Mrs. Bice of Oklahoma (for herself, Ms. Stefanik , Mr. Curtis , Mr. Lamborn , Mr. Carter of Georgia , Mr. Barr , Mr. Hill , Mr. Issa , Mrs. Miller-Meeks , Mr. Bacon , Mr. Cole , Mrs. Rodgers of Washington , and Ms. Letlow ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To preempt States from establishing, implementing, or enforcing any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception, and for other purposes.

1. Short title This Act may be cited as the Access to Safe Contraception Act of 2022 . 2. Preemption of State bans on FDA-approved products for contraception (a) Preemption No State shall establish, implement, or enforce any ban on the prescription, provision, or use of a drug, biological product, or device for contraception if such drug, biological product, or device is approved, licensed, cleared, or otherwise authorized for human use by the Food and Drug Administration for contraception. (b) Rules of construction Nothing in subsection (a) shall be construed— (1) to infringe the ability of a State to regulate the practice of medicine and pharmacy within such State; (2) to preempt the Religious Freedom Restoration Act of 1993 ( 42 U.S.C. 2000bb et seq. ); or (3) to preempt any State law to the extent such State law protects the right of any entity to opt out of providing contraception if such provision would be contrary to that entity’s religious or moral beliefs. (c) Definitions In this section: (1) The term biological product has the meaning given such term in section 351 of the Public Health Service Act ( 42 U.S.C. 262 ). (2) The terms device and drug have the meanings given such terms in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ).